Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008773 · ClinicalTrials.gov registry record · Phase 2
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
NCT02008773 is a Phase 2 study that has completed, run by Indiana University. The registered enrollment target is 170 participants.
The verdict
NCT02008773, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
Study Summary
The primary aim of the study is to determine the efficacy of adjunctive valacyclovir, in comparison to placebo, to improve visual (Brief Visuospatial Memory Test) and working (composite score of the Spatial Span and Letter Number Span tests) memory in individuals who are HSV-1 positive and early in the course of schizophrenia. We hypothesize that individuals who are HSV-1 positive, but not those who are HSV-1 negative, will demonstrate significant valacyclovir efficacy for visual and working memory.
Interventions
- DRUG placebo
- DRUG Valacyclovir HCI 500 mg tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2014-03-26 |
| Est. Completion | 2017-06-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02008773
The ClinicalTrials.gov registry entry for NCT02008773 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02008773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02008773 about?
NCT02008773 is a clinical study titled "A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia". The primary aim of the study is to determine the efficacy of adjunctive valacyclovir, in comparison to placebo, to improve visual (Brief Visuospatial Memory Test) and working (composite score of the Spatial Span and Letter Number Span tests) memory in individuals who are HSV-1 positive and early in ...
What is the current status of trial NCT02008773?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2014-03-26. Estimated completion is 2017-06-20.
What interventions are being tested in trial NCT02008773?
The interventions under investigation include: placebo (DRUG), Valacyclovir HCI 500 mg tablets (DRUG).
Who is sponsoring clinical trial NCT02008773?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.